Fosun Pharma in HK$1.76bn private placement
Shanghai Fosun Pharmaceutical Group has priced a HK$1.76bn ($227m) private placement to raise funds for debt repayment and to finance potential M&A.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts